Estimaciones de analistas de Wall Street para Citius Pharmaceuticals, Inc. (CTXR): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-12-22 | $-0.41 | ||
| 2026-12-17 | $-0.41 | ||
| 2026-08-14 | $-0.34 | $-0.36 | +5.6% |
| 2026-05-15 | $-0.95 | $-0.28 | -238.4% |
| 2026-02-13 | $-0.38 | $0.43 | -188.4% |
| 2025-12-26 | $-0.01 | $-0.43 | +97.7% |
| 2025-08-12 | $-0.80 | $-0.51 | -58.4% |
| 2025-05-14 | $-1.27 | $-1.08 | -17.6% |
Ratios de valoración
| Precio / Valor contable | 0.21 |
| EV / EBITDA | 0.06 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $1343 | $2632 | $1753 | $893 | $152364 | $164868 | 0 | 0 | $209611 | $214250 |
| Beneficio Bruto | -$1343 | -$2632 | -$1753 | -$893 | -$152364 | -$164868 | 0 | 0 | -$209611 | -$214250 |
| I+D | $2.9M | $2.9M | $6.6M | $8.6M | $8.8M | $12.2M | $17.7M | $14.8M | $11.9M | $9.2M |
| Generales y Administrativos | $4.5M | $7.1M | $7.2M | $7.0M | $8.7M | $11.1M | $15.7M | $21.9M | $18.2M | $18.5M |
| Gastos Operativos | $7.4M | $10.0M | $13.8M | $15.6M | $17.6M | $23.4M | $33.3M | $36.7M | $42.0M | $38.3M |
| Beneficio Operativo | -$7.4M | -$10.0M | -$13.8M | -$15.6M | -$17.7M | -$23.5M | -$33.3M | -$36.7M | -$42.0M | -$38.5M |
| EBITDA | -$7.4M | -$10.0M | -$13.8M | -$15.5M | -$17.6M | -$23.4M | -$33.1M | -$36.5M | -$38.6M | -$38.2M |
| Gastos por Intereses | $8994 | $850789 | $15838 | $16443 | $15673 | $10839 | 0 | 0 | 0 | $267782 |
| Beneficio Antes de Impuestos | -$8.3M | -$10.4M | -$12.5M | -$15.6M | -$17.5M | -$23.1M | -$33.1M | -$32.0M | -$38.8M | -$38.7M |
| Impuestos | $8994 | 0 | 0 | $16443 | 0 | 0 | $576000 | $576000 | $576000 | $1.1M |
| Beneficio Neto | -$8.3M | -$10.4M | -$12.5M | -$15.6M | -$17.5M | -$23.1M | -$33.6M | -$32.5M | -$39.1M | -$37.4M |
| BPA | $-2.29 | $-1.89 | $-1.17 | $-0.77 | $-11.20 | $-5.64 | $-5.75 | $-5.57 | $-5.97 | $-3.38 |
| BPA Diluido | $-2.29 | $-1.89 | $-1.17 | $-0.77 | $-11.20 | $-5.64 | $-5.75 | $-5.57 | $-5.97 | $-3.38 |
| Acciones en Circulación (Diluidas) | $241547 | $365500 | $715458 | $1.3M | $1.6M | $4.3M | $5.8M | $6.1M | $11.6M | $11.1M |
Precio
| Precio | $0.56 |
| Capitalización | $6M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ADTX · APLM · ATHA · CRIS · DARE · FBLG · ICU
Explorar sector: Healthcare · Biotechnology
Más secciones de CTXR: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones